FRANCISCO PARDO: Open Payments
NPI 1699844621 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 7 payments from 4 companies in 2025. Trend: 2023 $936 · 2024 $306 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $217 |
| Neurocrine BioSciences, Inc. | 1 | $172 |
| PFIZER INC. | 1 | $27 |
| ABBVIE INC. | 1 | $22 |
Products named: INGREZZA, Yeztugo, NURTEC ODT, MAVYRET.
Industry payments across CA — which companies pay providers there.
